{"id":33085,"date":"2017-10-02T17:16:45","date_gmt":"2017-10-02T15:16:45","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=33085"},"modified":"2017-10-19T19:50:41","modified_gmt":"2017-10-19T17:50:41","slug":"consiglio-le-regioni-non-possono-sconsigliare-luso-dei-farmaci","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/consiglio-le-regioni-non-possono-sconsigliare-luso-dei-farmaci\/","title":{"rendered":"The Council of State: the Regions cannot advise against the use of medicines"},"content":{"rendered":"<p class=\"first-letter\">The III Section of the Council of State upheld the appeal of the pharmaceutical company Roche, canceling the recommendations of the Veneto Region with which it was discouraged for operating doctors <img decoding=\"async\" class=\"alignright\" src=\"http:\/\/www.agite.eu\/images\/Lea_2017.jpg\" alt=\"Risultati immagini per lea livelli essenziali assistenza\" \/>in public hospitals the use of certain oncological drugs, duly authorized by Aifa - the Italian Medicines Agency, for the treatment of ovarian and breast cancer, and falling within the essential levels of assistance (so-called Lea).<\/p>\n<p><b>The Regions cannot limit the essential levels of assistance<\/b><br \/>\nIn sentence no. 4546 of 29 September 2017 Palazzo Spada reaffirmed the principle according to which the Regions cannot limit the essential levels of assistance, not even by &quot;recommending&quot; to doctors the use of some drugs over others, assessed as less convenient in terms of cost\/benefit ratio. These essential levels, in fact, must remain uniform throughout the country for the essential guarantee of the right to health (article 32 of the Constitution).<\/p>\n<p>(\u2026 continue on <a href=\"http:\/\/www.ilsole24ore.com\/art\/notizie\/2017-10-02\/il-consiglio-stato-regioni-non-possono-sconsigliare-l-uso-farmaci--135458.shtml?uuid=AEyBKFdC\" target=\"_blank\" rel=\"noopener\">Il Sole 24ORE del\u00a0<\/a><time>02 October 2017)<\/time><\/p>\n<p>Related news: <a href=\"https:\/\/www.giustizia-amministrativa.it\/cdsintra\/cdsintra\/AmministrazionePortale\/DocumentViewer\/index.html?ddocname=BK2FPR2GHLUS5C4IJWB5MUIQPY&amp;q=sezione%20or%203%20or%20Consiglio%20or%20di%20or%20Stato%20or%20roche\" target=\"_blank\" rel=\"noopener\">State Council. Judgment No. 04546\/2017 REG.PROV.COLL. N. 00706\/2016 REG.RIC<\/a><\/p>\n<p><a href=\"http:\/\/www.regioni.it\/dalleregioni\/2017\/10\/02\/farmaci-assessore-veneto-rispetto-consiglio-di-stato-ma-lo-stato-non-deve-sostituirsi-ai-clinici-che-prescrivono-in-scienza-e-coscienza-532446\/\" target=\"_blank\" rel=\"noopener\">Veneto Councilor, &quot;I respect the state council but the state must not replace the clinicians who prescribe in science and conscience&quot;.<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>La III Sezione del Consiglio di Stato ha accolto il ricorso della casa farmaceutica Roche, annullando le raccomandazioni della Regione Veneto con le quali \u00e8 stato sconsigliato ai medici operanti nelle strutture ospedaliere pubbliche l\u2019utilizzo di alcuni farmaci oncologici, regolarmente autorizzati dall\u2019Aifa \u2013 Agenzia italiana del farmaco, per la cura della carcinoma ovarico e di &hellip;<\/p>","protected":false},"author":4,"featured_media":22028,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[49,41,33,79],"class_list":["post-33085","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-primo-piano","tag-aifa","tag-leggisentenze","tag-roche","tag-ssn"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/33085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=33085"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/33085\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/22028"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=33085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=33085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=33085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}